Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis

Table 1 Measurement of cell survival rate by the 3-(4,5-dimethylthiazol-2-yl)-2-,5-diphenyltetrazolium bromide assay of pancreatic acinar cells at various time points (mean ± SD)

Group	0.5 h	1 h	4 h	10 h
Non-SODC group	93.83% ± 3.13%	89.00% ± 2.83%	81.83% ± 3.06%	75.00% ± 6.54%
SODC group	87.83% ± 6.59%a	77.50% ± 9.35%a	65.83% ± 8.23%a	39.17% ± 8.26%a
MSCs intervention group	90.00% ± 3.41%	82.17% ± 7.47%	75.17% ± 5.85%c	51.83% ± 6.79%c

^aP < 0.05 vs the non-sodium deoxycholate (SDOC) group,

^cP < 0.05 vs the SDOC group. MSCs: Mesenchymal stem cells.